<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04752917</url>
  </required_header>
  <id_info>
    <org_study_id>STH20161</org_study_id>
    <nct_id>NCT04752917</nct_id>
  </id_info>
  <brief_title>Do Noise Cancelling Headphones Reduce Sedation Requirements in Primary Knee Arthoplasty</brief_title>
  <acronym>NOISE</acronym>
  <official_title>Do Noise Cancelling Headphones Reduce Patient Controlled Midazolam Requirements in Primary Knee Arthroplasty Patients Under Spinal Anaesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheffield Teaching Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheffield Teaching Hospitals NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a randomised trial of headphones with midazolam patient controlled sedation&#xD;
      (intervention group) vs control group with no heaphones to compare sedation usage during knee&#xD;
      replacement surgery under spinal.&#xD;
&#xD;
      The trial is a pilot study of 20 cases&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is for patients undergoing elective primary knee replacement surgery under spinal&#xD;
      anaesthesia. It is proposed that using music played on noise cancelling headphones will&#xD;
      reduce the requirements for intravenous sedation in a randomised controlled trial of twenty&#xD;
      patients. Spinal anaesthesia is commonly used for knee replacement. It provides loss of&#xD;
      feeling from the operated limb but the patient remains awake. Orthopaedic surgery is very&#xD;
      noisy. It is usual for patients to receive intravenous sedation with midazolam to reduce&#xD;
      their awareness of surgery. Intravenous midazolam is effective but it depresses both the&#xD;
      breathing and the circulation and may cause low blood pressure and reduced oxygenation. It is&#xD;
      expected that by using noise cancelling headphones to reduce the awareness of noise during&#xD;
      surgery, there will be a reduced requirement for intravenous midazolam. The study will&#xD;
      measure the dose of midazolam required by patients randomised to receive either noise&#xD;
      cancelling headphones playing music (intervention) or no headphones (control group). Patients&#xD;
      will be followed up prior to hospital discharge to assess their awareness and recall of intra&#xD;
      operative events and their satisfaction with intravenous sedation. This is a novel&#xD;
      application of sound reducing technology capable of improving the patient experience during&#xD;
      surgery whilst potentially reducing complications of intravenous midazolam sedation. Noise&#xD;
      cancelling technology is readily available in commercially available headphones and it has&#xD;
      the potential to eliminate background noise of surgical procedures. This study findings will&#xD;
      be of interest for health professionals and patients involved in surgery or investigative&#xD;
      procedures normally carried out with intravenous sedation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 20, 2019</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised trial of control and intervention groups</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Unblinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change of sedation requirements during elective orthopaedic surgery.</measure>
    <time_frame>3 hours</time_frame>
    <description>Measuring the difference in intravenous sedation requirements for patient controlled midazolam during elective primary knee joint replacement surgery.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Anaesthesia</condition>
  <condition>Knee Surgery</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Headphones</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Noise Cancelling headphones</intervention_name>
    <description>Use of headphones playing patients choice of music</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elective primary knee surgery under spinal anaesthesia&#xD;
&#xD;
          -  Willing to receive patient controlled midazolam sedation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Deafness&#xD;
&#xD;
          -  Unwilling to use headphones&#xD;
&#xD;
          -  Unable to consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Marks, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sheffield Teaching Hospitals NHS Foundation Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Richard Marks, Dr</last_name>
    <phone>0114 2434343</phone>
    <email>richard.marks@sth.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Angela Pinder</last_name>
    <phone>0114 2265940</phone>
    <email>angela.pinder@nhs.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sheffield Teaching Hospitals NHS Foundation Trust</name>
      <address>
        <city>Sheffield</city>
        <state>South Yorkshire</state>
        <zip>S5 7AU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Marks, MB ChB BSc.</last_name>
      <phone>0114 2434343</phone>
      <email>richard.marks@sth.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Angela Pinder</last_name>
      <phone>0114 2265940</phone>
      <email>angela.pinder@nhs.net</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>August 29, 2019</study_first_submitted>
  <study_first_submitted_qc>February 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2021</study_first_posted>
  <last_update_submitted>February 9, 2021</last_update_submitted>
  <last_update_submitted_qc>February 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>This is pilot data and will hopefully lead to an application for a larger definitive study</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

